Eli Lilly & Co. (LLY) Tops Q4 EPS by 34c, Revenue Beats, Offers Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,145.86 +2.70%
Revenue Growth %: +25.9%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: +25.9%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.49, $0.34 better than the analyst estimate of $2.15. Revenue for the quarter came in at $8 billion versus the consensus estimate of $6.74 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $8.50-$8.65, versus the consensus of $7.54.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore cuts HPE rating amid 'tougher setup'
- Akebia doses first patient in Phase 2 kidney disease trial
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
